Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|August 26, 2022
Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO RegistryAnnabel Schulz, Eva Herrmann, Olivia Ott, et al.
Annals of Medicine|June 11, 2013
Laboratory testing of rivaroxaban in routine clinical practice: when, how, and which assaysEdelgard Lindhoff-Last, Jack Ansell, Theodore Spiro, et al.
Therapeutic Drug Monitoring|March 1, 2014
Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulantHelen Mani, Natalie Herth, Alexander Kasper, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2003
Acquired protein C and protein S deficiency in HIV-infected patientsMatthias Erbe, Volker Rickerts, Rupert Martin Bauersachs, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 8, 2008
A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparinFrank Gerdsen, Beate Luxembourg, Florian Langer, et al.
Lancet (London, England)|May 31, 2012
Heparin-induced skin lesionsMarc Schindewolf, Edelgard Lindhoff-Last, Ralf J Ludwig, et al.
Thrombosis and Haemostasis|July 29, 2024
Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance ReviewTruman J Milling, Anna Voronov, Dirk S Schmidt, et al.
Pathophysiology of Haemostasis and Thrombosis|November 19, 2005
Platelet activation markers in patients with venous thromboembolism without predisposing factorsFrank Gerdsen, Martin Weber, Florian Langer, et al.
Thrombosis Research|October 11, 2011
Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative diseaseBirgit Linnemann, Christiane Kraft, Martin Roskos, et al.
Cerebrovascular Diseases (Basel, Switzerland)|September 14, 2013
The gap between trial data and clinical practice -- an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulationWaltraud Pfeilschifter, Sebastian Luger, Robert Brunkhorst, et al.
Pageof 10